These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 2108451)
1. Metabolism and action of amino acid analog anti-cancer agents. Ahluwalia GS; Grem JL; Hao Z; Cooney DA Pharmacol Ther; 1990; 46(2):243-71. PubMed ID: 2108451 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of glutathione synthesis in the liver leads to S-adenosyl-L-methionine synthetase reduction. Corrales F; Ochoa P; Rivas C; Martin-Lomas M; Mato JM; Pajares MA Hepatology; 1991 Sep; 14(3):528-33. PubMed ID: 1874498 [TBL] [Abstract][Full Text] [Related]
3. Effects of methionine sulfoximine analogs on the synthesis of glutamine and glutathione: possible chemotherapeutic implications. Meister A; Griffith OW Cancer Treat Rep; 1979 Jun; 63(6):1115-21. PubMed ID: 38004 [No Abstract] [Full Text] [Related]
4. Pharmacodynamics of prolonged treatment with L,S-buthionine sulfoximine. Malaker K; Hurwitz SJ; Bump EA; Griffith OW; Lai LL; Riese N; Coleman CN Int J Radiat Oncol Biol Phys; 1994 May; 29(2):407-12. PubMed ID: 7910818 [TBL] [Abstract][Full Text] [Related]
5. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines. Mistry P; Loh SY; Kelland LR; Harrap KR Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583 [TBL] [Abstract][Full Text] [Related]
6. Buthionine sulfoximine pretreatment potentiates the effect of isolated lung perfusion with doxorubicin. Port JL; Hochwald SN; Wang HY; Burt ME Ann Thorac Surg; 1995 Aug; 60(2):239-43; discussion 244. PubMed ID: 7544099 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin. Brooks SE; Korbut TT; Dupuis NP; Holden SA; Teicher BA Cancer Chemother Pharmacol; 1995; 36(5):431-8. PubMed ID: 7634385 [TBL] [Abstract][Full Text] [Related]
8. Mechanisms and modulation of multidrug resistance in primary human renal cell carcinoma. Mickisch GH; Roehrich K; Koessig J; Forster S; Tschada RK; Alken PM J Urol; 1990 Sep; 144(3):755-9. PubMed ID: 1974934 [TBL] [Abstract][Full Text] [Related]
9. Buthionine sulfoximine spares intracellular glutamate: a possible mechanism for cell growth stimulation. Kang YJ Cell Mol Biol Res; 1993; 39(7):675-84. PubMed ID: 8055000 [TBL] [Abstract][Full Text] [Related]
10. Bioavailability of dietary glutathione: effect on plasma concentration. Hagen TM; Wierzbicka GT; Sillau AH; Bowman BB; Jones DP Am J Physiol; 1990 Oct; 259(4 Pt 1):G524-9. PubMed ID: 2221062 [TBL] [Abstract][Full Text] [Related]
12. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation. Shrieve DC; Harris JW Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936 [TBL] [Abstract][Full Text] [Related]
18. Nutritional requirements of Plasmodium falciparum in culture. III. Further observations on essential nutrients and antimetabolites. Geary TG; Divo AA; Bonanni LC; Jensen JB J Protozool; 1985 Nov; 32(4):608-13. PubMed ID: 2866244 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and transport of glutathione by cultured human retinal pigment epithelial cells. Davidson PC; Sternberg P; Jones DP; Reed RL Invest Ophthalmol Vis Sci; 1994 May; 35(6):2843-9. PubMed ID: 8188479 [TBL] [Abstract][Full Text] [Related]
20. Changes in the glutathione content of rat 9L cells induced by treatment with the ornithine decarboxylase inhibitor alpha-difluoromethylornithine. Hunter KJ; Deen DF; Marton LJ Cancer Res; 1987 Oct; 47(20):5270-3. PubMed ID: 3115562 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]